Abstract
CA 125 is an epithelial membrane marker which can be detected in the serum of patients with ovarian cancer and which may reflect tumour burden. In a group of 42 patients, the level of this marker has also been shown to be significantly related to survival.
Full text
PDFPage 22
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bagshawe K. D. Risk and prognostic factors in trophoblastic neoplasia. Cancer. 1976 Sep;38(3):1373–1385. doi: 10.1002/1097-0142(197609)38:3<1373::aid-cncr2820380342>3.0.co;2-e. [DOI] [PubMed] [Google Scholar]
- Bast R. C., Jr, Klug T. L., St John E., Jenison E., Niloff J. M., Lazarus H., Berkowitz R. S., Leavitt T., Griffiths C. T., Parker L. A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer. N Engl J Med. 1983 Oct 13;309(15):883–887. doi: 10.1056/NEJM198310133091503. [DOI] [PubMed] [Google Scholar]
- Germa-Lluch J. R., Begent R. H., Bagshawe K. D. Tumour-marker levels and prognosis in malignant teratoma of the testis. Br J Cancer. 1980 Dec;42(6):850–855. doi: 10.1038/bjc.1980.332. [DOI] [PMC free article] [PubMed] [Google Scholar]